Delay of Aortic Arterial Input Function Time Improves Detection of Malignant Vertebral Body Lesions on Dynamic Contrast-Enhanced MRI Perfusion
Abstract
:Simple Summary
Abstract
1. Introduction
2. Methods
2.1. Subjects
2.2. Magnetic Resonance Imaging Acquisition
2.3. Preprocessing
2.4. AIF Tissue Delay and Shift of Aorta Response
2.5. Statistical Analyses
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sasan, K.; Cho, N.S.; Peck, K.K.; Holodny, A.I. The Role of Advanced Imaging in Spinal Metastases. In Central Nervous System Metastases: Diagnosis and Treatment; Ramakrishna, R., Magge, R.S., Baaj, A.A., Knisely, J.P.S., Eds.; Springer International Publishing: Cham, Switzerland, 2020; pp. 523–534. [Google Scholar]
- Guan, Y.; Peck, K.K.; Lyo, J.; Tisnado, J.; Lis, E.; Arevalo-Perez, J.; Yamada, Y.; Hameed, M.R.; Karimi, S.; Holodny, A. T1-Weighted Dynamic Contrast-Enhanced Mri to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine. Radiology 2020, 297, 382–389. [Google Scholar] [CrossRef] [PubMed]
- Arevalo-Perez, J.; Peck, K.K.; Lyo, J.K.; Holodny, A.I.; Lis, E.; Karimi, S. Differentiating Benign from Malignant Vertebral Fractures Using T1-Weighted Dynamic Contrast-Enhanced Mri. J. Magn. Reson. Imaging 2015, 42, 1039–1047. [Google Scholar] [CrossRef] [PubMed]
- Chen, W.T.; Shih, T.T.; Chen, R.C.; Lo, H.Y.; Chou, C.T.; Lee, J.M.; Tu, H.Y. Blood Perfusion of Vertebral Lesions Evaluated with Gadolinium-Enhanced Dynamic Mri: In Comparison with Compression Fracture and Metastasis. J. Magn. Reson. Imaging 2002, 15, 308–314. [Google Scholar] [CrossRef] [PubMed]
- Morales, K.A.; Arevalo-Perez, J.; Peck, K.K.; Holodny, A.I.; Lis, E.; Karimi, S. Differentiating Atypical Hemangiomas and Metastatic Vertebral Lesions: The Role of T1-Weighted Dynamic Contrast-Enhanced Mri. AJNR Am. J. Neuroradiol. 2018, 39, 968–973. [Google Scholar] [CrossRef] [PubMed]
- Khadem, N.R.; Karimi, S.; Peck, K.K.; Yamada, Y.; Lis, E.; Lyo, J.; Bilsky, M.; Vargas, H.A.; Holodny, A.I. Characterizing Hypervascular and Hypovascular Metastases and Normal Bone Marrow of the Spine Using Dynamic Contrast-Enhanced Mr Imaging. AJNR Am. J. Neuroradiol. 2012, 33, 2178–2185. [Google Scholar] [CrossRef] [PubMed]
- Saha, A.; Peck, K.K.; Lis, E.; Holodny, A.I.; Yamada, Y.; Karimi, S. Magnetic Resonance Perfusion Characteristics of Hypervascular Renal and Hypovascular Prostate Spinal Metastases: Clinical Utilities and Implications. Spine 2014, 39, E1433–E1440. [Google Scholar] [CrossRef] [PubMed]
- Santos, P.; Peck, K.K.; Arevalo-Perez, J.; Karimi, S.; Lis, E.; Yamada, Y.; Holodny, A.I.; Lyo, J. T1-Weighted Dynamic Contrast-Enhanced Mr Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma. AJNR Am. J. Neuroradiol. 2017, 38, 2210–2216. [Google Scholar] [CrossRef] [PubMed]
- Kumar, K.A.; Peck, K.K.; Karimi, S.; Lis, E.; Holodny, A.I.; Bilsky, M.H.; Yamada, Y. A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion Mri to Predict Local Recurrence after Radiosurgery on Spinal Metastases. Technol. Cancer Res. Treat. 2017, 16, 857–865. [Google Scholar] [CrossRef] [PubMed]
- Lis, E.; Saha, A.; Peck, K.K.; Zatcky, J.; Zelefsky, M.J.; Yamada, Y.; Holodny, A.I.; Bilsky, M.H.; Karimi, S. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Osseous Spine Metastasis before and 1 Hour after High-Dose Image-Guided Radiation Therapy. Neurosurg. Focus 2017, 42, E9. [Google Scholar] [CrossRef] [PubMed]
- Chu, S.; Karimi, S.; Peck, K.K.; Yamada, Y.; Lis, E.; Lyo, J.; Bilsky, M.; Holodny, A.I. Measurement of Blood Perfusion in Spinal Metastases with Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Evaluation of Tumor Response to Radiation Therapy. Spine 2013, 38, E1418–E1424. [Google Scholar] [CrossRef] [PubMed]
- Tofts, P.S.; Brix, G.; Buckley, D.L.; Evelhoch, J.L.; Henderson, E.; Knopp, M.V.; Larsson, H.B.; Lee, T.Y.; Mayr, N.A.; Parker, G.J.; et al. Estimating Kinetic Parameters from Dynamic Contrast-Enhanced T1-Weighted Mri of a Diffusable Tracer: Standardized Quantities and Symbols. J. Magn. Reson. Imaging 1999, 10, 223–232. [Google Scholar] [CrossRef]
- Leach, M.O.; Brindle, K.M.; Evelhoch, J.L.; Griffiths, J.R.; Horsman, M.R.; Jackson, A.; Jayson, G.C.; Judson, I.R.; Knopp, M.V.; Maxwell, R.J.; et al. The Assessment of Antiangiogenic and Antivascular Therapies in Early-Stage Clinical Trials Using Magnetic Resonance Imaging: Issues and Recommendations. Br. J. Cancer 2005, 92, 1599–1610. [Google Scholar] [CrossRef] [PubMed]
- Sourbron, S.P.; Buckley, D.L. Tracer Kinetic Modelling in Mri: Estimating Perfusion and Capillary Permeability. Phys. Med. Biol. 2012, 57, R1–R33. [Google Scholar] [CrossRef] [PubMed]
- Filice, S.; Crisi, G. Dynamic Contrast-Enhanced Perfusion Mri of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function. J. Neuroimaging 2016, 26, 124–129. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.J.; Yang, H.T.; Yao, M.M.; Lin, S.C.; Cho, D.Y.; Shen, W.C.; Juan, C.J.; Chan, W.P. Quantifying Lumbar Vertebral Perfusion by a Tofts Model on Dce-Mri Using Segmental Versus Aortic Arterial Input Function. Sci. Rep. 2021, 11, 2920. [Google Scholar] [CrossRef] [PubMed]
- Lavini, C.; Kramer, G.; Bos, I.P.-D.; Hoekstra, O.; Marcus, J.T. Mri Protocol Optimization for Quantitative Dce-Mri of the Spine. J. Magn. Reson. Imaging 2017, 44, 96–103. [Google Scholar] [CrossRef] [PubMed]
Patient | Gender | Age | Primary Cancer | Location | Pretreatment from Perfusion Date |
---|---|---|---|---|---|
1 | F | 69 | Cholangiocarcinoma | L3 | Chemotherapy |
2 | M | 55 | Breast Cancer | T10 T11, (previous L2 metastases) | Chemotherapy |
3 | M | 62 | Renal Cell Carcinoma | T12, L3 | Chemotherapy |
4 | F | 71 | Lung Adenocarcinoma | C7 | None |
5 | M | 75 | Multiple Myeloma | T6, T7, T12, L1 | Chemotherapy |
6 | M | 63 | Cholangiocarcinoma | L3, L4 | Chemotherapy |
7 | M | 53 | Colon Cancer | L2 L3 | Chemotherapy |
8 | F | 50 | Colon Cancer | L3 | Chemotherapy |
9 | M | 80 | Myoepithelioma | S2 | RT two years prior |
10 | F | 63 | Thymoma | T9 | Resections, RT, Chemo |
11 | F | 50 | Renal Cancer | T12 | None |
12 | F | 53 | NSCLC | L2 | none |
13 | M | 74 | Thymoma | L4 | None |
14 | M | 55 | Melanoma | L2, L3 | Immunotherapy |
15 | M | 63 | Prostate | T5 and Sacrum | None |
16 | M | 62 | Colon Cancer | L5-S3 | None |
17 | F | 61 | NSCLC | T7 T8 | Chemotherapy |
18 | M | 37 | Renal Cancer | L4 | None |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Camelo, F.; Peck, K.K.; Saha, A.; Arevalo-Perez, J.; Lyo, J.K.; Tisnado, J.; Lis, E.; Karimi, S.; Holodny, A.I. Delay of Aortic Arterial Input Function Time Improves Detection of Malignant Vertebral Body Lesions on Dynamic Contrast-Enhanced MRI Perfusion. Cancers 2023, 15, 2353. https://doi.org/10.3390/cancers15082353
Camelo F, Peck KK, Saha A, Arevalo-Perez J, Lyo JK, Tisnado J, Lis E, Karimi S, Holodny AI. Delay of Aortic Arterial Input Function Time Improves Detection of Malignant Vertebral Body Lesions on Dynamic Contrast-Enhanced MRI Perfusion. Cancers. 2023; 15(8):2353. https://doi.org/10.3390/cancers15082353
Chicago/Turabian StyleCamelo, Felipe, Kyung K. Peck, Atin Saha, Julio Arevalo-Perez, John K. Lyo, Jamie Tisnado, Eric Lis, Sasan Karimi, and Andrei I. Holodny. 2023. "Delay of Aortic Arterial Input Function Time Improves Detection of Malignant Vertebral Body Lesions on Dynamic Contrast-Enhanced MRI Perfusion" Cancers 15, no. 8: 2353. https://doi.org/10.3390/cancers15082353